Role of Presenilins in Capacitative Calcium Entry
About the Research Project
Program
Award Type
Standard
Award Amount
$190,000
Active Dates
April 01, 2000 - March 31, 2002
Grant ID
A2000002
Acknowledgement
Summary
When the normal intracellular stores of calcium are depleted, a response is triggered inside the cell that leads to the influx of calcium from outside the cell. This process is known as capacitative calcium entry, or CCE. Dr. Tae-Wan Kim has found that mutations in presenilin 1 (PS1) or presenilin 2 (PS2) that cause inherited AD are associated with an impaired CCE response. It has also been found that treating cells with an inhibitor of the CCE response causes an increase in the expression of the protein Ab42. This suggests that the CCE response is coupled with the gamma secretase activity associated with PS1, and that it causes the production of Ab42. Dr. Kim is examining these relationships in more detail to determine whether the reduction of CCE is an early event in AD. He also hopes to determine whether increasing CCE response reduces gamma secretase activity. If it does, this result would raise the possibility that drugs that stimulate CCE could lead to the decreased production of Ab42 and the progression of AD.
Related Grants
Alzheimer's Disease Research
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
"Cognition in a Dish" to Develop New Alzheimer’s Therapies
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Matthias Hebisch, PhD
Current Organization
Massachusetts General Hospital
Alzheimer's Disease Research
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Why Alzheimer’s Disease Targets Some Cells First: A Clue in the Anterior Hypothalamus
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Gowoon Son, PhD
Current Organization
Mayo Clinic Jacksonville
Alzheimer's Disease Research
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University
Probing the Novel Roles of Neuromodulators in Alzheimer’s Disease
Active Dates
July 01, 2026 - June 30, 2029
Principal Investigator
Fikri Birey, PhD
Current Organization
Emory University